Health
Vaccine experts meeting over clot report – Hepburn Advocate
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians. The Therapeutic……
A Melbourne man’s rare blood clotting disorder, likely linked to the AstraZeneca COVID-19 vaccine, will not affect its rollout to Australians.
The Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation met on Saturday morning and Acting Chief Medical Officer Michael Kidd said no changes to the AstraZeneca rollout were recommended.
He said it was likely, given similarities with rare overseas cases, that the man’s clotting disorder was related to him receiving the…
-
General24 hours agoThis isn’t progress, it’s punishment
-
General23 hours agoMitch Marsh inspires Australia to three-wicket win over New Zealand in third T20I
-
General22 hours agoNothing to see here *wink wink*
-
General20 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup